Activity Provided By:

Physicians’ Education Resource®, LLC

Community Practice Connections™: The Role of Anticoagulants for Secondary Prevention in Patients With CAD and PAD: When Should Therapy Be Initiated?

Overview / Abstract:	Target Audience This educational program is directed toward cardiologists and cardiology subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with CAD and PAD are invited to participate. Activity Overview This online virtual symposium brings renowned experts in atherosclerotic disease together to provide attendees with commentary on state-of-the-art management and prevention of coronary artery disease (CAD) and peripheral arterial disease (PAD), with antithrombotic strategies. Atherosclerosis is a key pathogenetic mechanism that underlies clinical conditions that account for the top causes of mortality and mortality among Americans—CAD and PAD. Despite advances in the care of patients with these diseases, opportunities remain to improve the delivery of care to affected patients through ongoing clinician education and professional development. Focus is placed on reducing the risk of secondary events in these patients. By coupling practice-focused, slide-based presentations with engaging patient-case vignettes, faculty highlight current recommendations that constitute best practices. This Community Practice Connection™ program provides a review of some of the key highlights from a live virtual symposium held on November 17, 2020. This unique and engaging multimedia activity is ideal for the community-based clinician, as it helps to place recent clinical trial data within a clinical context. The program is designed for those who did not attend the live meeting and would help to reinforce learning for those who did. Learning Objectives Upon completion of this activity, participants should be better able to: Describe the role of novel antithrombotic strategies in the secondary prevention setting Identify strategies for reducing the risk of additional events in patients with existing CAD and PAD Evaluate the efficacy and safety of antithrombotic strategies used to mitigate cardiovascular risk in patients with CAD and PAD
Expiration	Jan 15, 2022
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1.50 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME
Presenters / Authors / Faculty	Faculty FACULTY_NAME Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Executive Director of Interventional Cardiovascular Programs Brigham and Women’s Hospital Heart & Vascular Center Professor of Medicine, Harvard Medical School Boston, MA FACULTY_NAME Kelley R. Branch, MD, MS Associate Professor of Medicine Director, Cardiovascular Clinical Trials Associate Director, Clinical Trials Service Unit Attending Physician University of Washington Medical Center Seattle, WA FACULTY_NAME Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA Gerald S. Berenson Endowed Chair in Preventive Cardiology Professor of Medicine, John W. Deming Department of Medicine Tulane University School of Medicine New Orleans, LA
Sponsors / Supporters / Grant Providers	Faculty FACULTY_NAME Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Executive Director of Interventional Cardiovascular Programs Brigham and Women’s Hospital Heart & Vascular Center Professor of Medicine, Harvard Medical School Boston, MA FACULTY_NAME Kelley R. Branch, MD, MS Associate Professor of Medicine Director, Cardiovascular Clinical Trials Associate Director, Clinical Trials Service Unit Attending Physician University of Washington Medical Center Seattle, WA FACULTY_NAME Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA Gerald S. Berenson Endowed Chair in Preventive Cardiology Professor of Medicine, John W. Deming Department of Medicine Tulane University School of Medicine New Orleans, LA
Keywords / Search Terms	Relias LLC Relias LLC., FREE CME., Anticoagulants, CAD , PAD Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map